Page last updated: 2024-09-05

migalastat and Cardiomyopathy, Hypertrophic Obstructive

migalastat has been researched along with Cardiomyopathy, Hypertrophic Obstructive in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gensler, D; Müntze, J; Nordbeck, P; Salinger, T; Wanner, C1

Other Studies

1 other study(ies) available for migalastat and Cardiomyopathy, Hypertrophic Obstructive

ArticleYear
Treatment of hypertrophic cardiomyopathy caused by cardiospecific variants of Fabry disease with chaperone therapy.
    European heart journal, 2018, 05-21, Volume: 39, Issue:20

    Topics: 1-Deoxynojirimycin; Cardiomyopathy, Hypertrophic; Echocardiography; Electrocardiography; Fabry Disease; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Molecular Chaperones

2018
chemdatabank.com